AIFF
What one share of Firefly Neuroscience holds
Services – Prepackaged Software
Firefly Neuroscience, Inc. is an artificial intelligence company advancing precision neuroscience, applying AI and large-scale electrophysiological data to give clinicians a more complete, objective picture of how an individual patient's brain is functioning.
Firefly Neuroscience’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.12 |
|---|---|
| Profit | −$0.60 |
| Cash and investments | $0.59 |
| Book value | $0.93 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $180.21 | −$14.83 | $0.36 | −$7.23 | — | $43.72 |
| 2017 | $275.58 | $6.00 | $0.02 | $21.63 | — | $50.72 |
| 2019 | $272.07 | −$18.00 | $0.22 | −$24.77 | — | $31.10 |
| 2020 | $346.15 | $9.00 | $1.61 | $8.93 | — | $42.98 |
| 2021 | $358.68 | −$26.99 | $1.66 | −$19.20 | — | $303.51 |
| 2022 | $6.80 | −$10.04 | $0.30 | −$3.70 | — | −$1.16 |
| 2023 | $0.15 | −$0.81 | $0.00 | −$0.67 | — | $0.03 |
| 2024 | $0.02 | −$1.60 | — | −$0.94 | — | −$0.05 |
| 2025 | $0.09 | −$1.97 | — | −$0.66 | — | $0.55 |